|
1
|
- ד"ר יורם נוימן
- בית חולים מאיר
- כפר-סבא
|
|
2
|
|
|
3
|
- Major criteria
- Blood culture positive for infective endocaditis
- Evidence of endocardial involvement
- Oscillating intracardiac mass on a valve or supporting structure, in
the path of regurgitant jets or on implanted material.
- Abscess
- New or partial dehiscence of a prosthetic valve
- New valvular regurgitation (worsening or changing of pre-existing
murmur- not sufficient)
|
|
4
|
- Minor Criteria
- Predisposition- heart condition, IV abuse
- Fever (>380C)
- Vascular phenomena
- Immunologic phenomena
- Atypical blood culture results
|
|
5
|
- Definite Infective Endocarditis-
- 2 major criteria, or
- 1 major and 3 minor, or
- 5 minor
- possible Infective Endocarditis-
- 1 major and 1 minor, or
- 3 minor
|
|
6
|
|
|
7
|
- בן 30, ספורטאי.
- התאשפז עקב כאבי חזה, ללא עדות לאיסכמיה.
- שבועיים טרם אישפוזו, עבר ברור בבי"ח אחר עקב חולשה
וחוסר תחושה ביד שמאל תוך כדי ריצה.
- ב-CT מוח, ממצא החשוד כאוטם ב-capsula interna.
- ב-TTE, ממצא ע"פ המסתם האאורטלי.
|
|
8
|
|
|
9
|
|
|
10
|
|
|
11
|
- בת 82
- התאשפזה עקב חום 38.2, חולשה ובלבול.
- 3 תרביות עם צמיחה של
Strep Gr A
- בברור עקב הדרדרות במצבה וללא מציאת מקור זיהומי-
- ב-TTE ללא עדות לאנדוקרדיטיס
- ב-TEE-
|
|
12
|
|
|
13
|
|
|
14
|
|
|
15
|
|
|
16
|
|
|
17
|
|
|
18
|
|
|
19
|
|
|
20
|
|
|
21
|
- בן 66
- ברקע- מחלת לב איסכמית- עבר 3 אוטמים.
- בברור כאבי גב אובחנה אוסטאומיאליטיס של חוליות מותניות.
- עבר ניקוז ניתוחי (לא היתה צמיחה).
- במהלך לאחר הניתוח- בצקת ריאות.
- באקו-
|
|
22
|
|
|
23
|
|
|
24
|
|
|
25
|
|
|
26
|
|
|
27
|
|
|
28
|
|
|
29
|
|
|
30
|
|
|
31
|
|
|
32
|
|
|
33
|
|
|
34
|
|
|
35
|
- CHF-
- Greatest impact on prognosis (regardless of its cause!). Therefore early surgery!
- The decision to delay surgery to extent the duration of preoperative
antibiotic therapy should be discouraged.
- Powerful predictor of a poor outcome with surgical therapy as well….
|
|
36
|
|
|
37
|
|
|
38
|
- Class I
- 1. Surgery of the native valve is indicated in patients with acute
infective endocarditis who present with valve stenosis or regurgitation
resulting in heart failure. (Level of Evidence: B)
- 2. Surgery of the native valve is indicated in patients with acute
infective endocarditis who present with AR or MR with hemodynamic
evidence of elevated LV end diastolic or left atrial pressures (e.g.,
premature closure of MV with AR, rapid decelerating MR signal by
continuous-wave Doppler (v-wave cutoff sign), or moderate or severe
pulmonary hypertension). (Level of Evidence: B)
- 3. Surgery of the native valve is indicated in patients with infective
endocarditis caused by fungal or other highly resistant organisms. (Level
of Evidence: B)
- 4. Surgery of the native valve is indicated in patients with infective
endocarditis complicated by heart block, annular or aortic abscess, or
destructive penetrating lesions (e.g., sinus of Valsalva to right
atrium, right ventricle, or left
atrium fistula; mitral leaflet perforation with aortic valve
endocarditis; or infection in annulus fibrosa). (Level of Evidence: B).
-
(ACC/AHA practice guidelines 2006)
|
|
39
|
- Class IIa
- Surgery of the native valve is reasonable in patients with infective
endocarditis who present with recurrent emboli and persistent
vegetations despite appropriate antibiotic therapy. (Level of Evidence:
C)
- Class IIb
- Surgery of the native valve may be considered in patients with infective
endocarditis who present with mobile vegetations in excess of 10 mm with
or without emboli. (Level of Evidence: C)
|
|
40
|
- בן 55, מעשן.
- מזה 5 ימים חום עד 39.
- עבר ניתוח ברך לפני 4 חודשים ומאז מספר אירועי חום שחלפו
עצמונית.
- בלילה טרם קבלתו- כאב ראש חזק, חולשה בפלג גוף ימני.
- ב-CT- ממצא פריאטו-אוקסיפיטלי משמאל-
באבחנה מבדלת בין אנצפליטיס לאוטם חריף.
- ב-TTE מסתם אאורטלי מסוייד ודולף
- ב-TEE-
|
|
41
|
|
|
42
|
|
|
43
|
|
|
44
|
|
|
45
|
- Class I
- 1. Surgery of the native valve is indicated in patients with acute
infective endocarditis who present with valve stenosis or regurgitation
resulting in heart failure. (Level of Evidence: B)
- 2. Surgery of the native valve is indicated in patients with acute
infective endocarditis who present with AR or MR with hemodynamic
evidence of elevated LV end diastolic or left atrial pressures (e.g.,
premature closure of MV with AR, rapid decelerating MR signal by
continuous-wave Doppler (v-wave cutoff sign), or moderate or severe
pulmonary hypertension). (Level of Evidence: B)
- 3. Surgery of the native valve is indicated in patients with infective
endocarditis caused by fungal or other highly resistant organisms. (Level
of Evidence: B)
- 4. Surgery of the native valve is indicated in patients with infective
endocarditis complicated by heart block, annular or aortic abscess, or
destructive penetrating lesions (e.g., sinus of Valsalva to right
atrium, right ventricle, or left
atrium fistula; mitral leaflet perforation with aortic valve
endocarditis; or infection in annulus fibrosa). (Level of Evidence: B).
-
(ACC/AHA practice guidelines 2006)
|
|
46
|
|
|
47
|
|
|
48
|
|
|
49
|
|
|
50
|
|
|
51
|
|
|
52
|
|
|
53
|
|
|
54
|
|
|
55
|
- Class I
- 1. Surgery of the native valve is indicated in patients with acute
infective endocarditis who present with valve stenosis or regurgitation
resulting in heart failure. (Level of Evidence: B)
- 2. Surgery of the native valve is indicated in patients with acute
infective endocarditis who present with AR or MR with hemodynamic
evidence of elevated LV end diastolic or left atrial pressures (e.g.,
premature closure of MV with AR, rapid decelerating MR signal by
continuous-wave Doppler (v-wave cutoff sign), or moderate or severe
pulmonary hypertension). (Level of Evidence: B)
- 3. Surgery of the native valve is indicated in patients with infective
endocarditis caused by fungal or other highly resistant organisms. (Level
of Evidence: B)
- 4. Surgery of the native valve is indicated in patients with infective
endocarditis complicated by heart block, annular or aortic abscess, or
destructive penetrating lesions (e.g., sinus of Valsalva to right
atrium, right ventricle, or left
atrium fistula; mitral leaflet perforation with aortic valve
endocarditis; or infection in annulus fibrosa). (Level of Evidence: B).
-
(ACC/AHA practice guidelines 2006)
|
|
56
|
- בת 68
- ברקע
- השמנת יתר, יל"ד, היפרליפידמיה.
- התאשפזה עקב חום, כאבי בטן ושלשול.
- במיון- הונשמה עקב אי ספיקה נשימתית.
- בתרביות דם- MSSA
- ב-TEE
|
|
57
|
|
|
58
|
|
|
59
|
|
|
60
|
|
|
61
|
|
|
62
|
|
|
63
|
|
|
64
|
|
|
65
|
|
|
66
|
- Class I
- 1. Surgery of the native valve is indicated in patients with acute
infective endocarditis who present with valve stenosis or regurgitation
resulting in heart failure. (Level of Evidence: B)
- 2. Surgery of the native valve is indicated in patients with acute
infective endocarditis who present with AR or MR with hemodynamic
evidence of elevated LV end diastolic or left atrial pressures (e.g.,
premature closure of MV with AR, rapid decelerating MR signal by
continuous-wave Doppler (v-wave cutoff sign), or moderate or severe
pulmonary hypertension). (Level of Evidence: B)
- 3. Surgery of the native valve is indicated in patients with infective
endocarditis caused by fungal or other highly resistant organisms. (Level
of Evidence: B)
- 4. Surgery of the native valve is indicated in patients with infective
endocarditis complicated by heart block, annular or aortic abscess, or
destructive penetrating lesions (e.g., sinus of Valsalva to right
atrium, right ventricle, or left
atrium fistula; mitral leaflet perforation with aortic valve
endocarditis; or infection in annulus fibrosa). (Level of Evidence: B).
-
(ACC/AHA practice guidelines 2006)
|
|
67
|
- בת 87, דמנטית.
- CABG+AVR ב-1992
- התקבלה עקב מחלה חום שנמשכה כ-5 ימים.
- בתרביות דם- Enterococci.
- TTE לא אבחנתי
- ב-TEE-
|
|
68
|
|
|
69
|
|
|
70
|
|
|
71
|
|
|
72
|
- Class I
- 1. Consultation with a cardiac surgeon is indicated for patients with
infective endocarditis of a prosthetic valve. (Level of Evidence: C)
- 2. Surgery is indicated for patients with infective endocarditis of a
prosthetic valve who present with heart failure. (Level of Evidence: B)
- 3. Surgery is indicated for patients with infective endocarditis of a
prosthetic valve who present with dehiscence evidenced by cine
fluoroscopy or echocardiography. (Level of Evidence: B)
- 4. Surgery is indicated for patients with infective endocarditis of a
prosthetic valve who present with evidence of increasing obstruction or
worsening regurgitation. (Level of Evidence: C)
- Surgery is indicated for patients with infective endocarditis of a
prosthetic valve who present with complications, for example, abscess
formation. (Level of Evidence: C)
- (ACC/AHA
practice guidelines 2006)
|
|
73
|
- Class IIa
- 1. Surgery is reasonable for patients with infective endocarditis of a
prosthetic valve who present with evidence of persistent bacteremia or
recurrent emboli despite appropriate antibiotic treatment. (Level of
Evidence: C)
- 2. Surgery is reasonable for patients with infective endocarditis of a
prosthetic valve who present with relapsing infection. (Level of
Evidence: C)
- Class III
- Routine surgery is not indicated for patients with uncomplicated
infective endocarditis of a prosthetic valve caused by first infection
with a sensitive organism. (Level of Evidence: C)
-
(ACC/AHA practice guidelines 2006)
|
|
74
|
|
|
75
|
|
|
76
|
|
|
77
|
|
|
78
|
|
|
79
|
|
|
80
|
|
|
81
|
|
|
82
|
|
|
83
|
|
|
84
|
- Class I
- 1. Consultation with a cardiac surgeon is indicated for patients with
infective endocarditis of a prosthetic valve. (Level of Evidence: C)
- 2. Surgery is indicated for patients with infective endocarditis of a
prosthetic valve who present with heart failure. (Level of Evidence: B)
- 3. Surgery is indicated for patients with infective endocarditis of a
prosthetic valve who present with dehiscence evidenced by cine
fluoroscopy or echocardiography. (Level of Evidence: B)
- 4. Surgery is indicated for patients with infective endocarditis of a
prosthetic valve who present with evidence of increasing obstruction or
worsening regurgitation. (Level of Evidence: C)
- Surgery is indicated for patients with infective endocarditis of a
prosthetic valve who present with complications, for example, abscess
formation. (Level of Evidence: C)
- (ACC/AHA
practice guidelines 2006)
|
|
85
|
- בן 60
- ברקע- השמנת יתר וקוצב לב קבוע.
- התאשפז עקב מחלת חום.
- בתרביות דם- MSSA
- TTE לא הדגים מקור זיהומי
- ב-TEE
|
|
86
|
|
|
87
|
|
|
88
|
|
|
89
|
- Early x
- Echocardiography as soon as possible (<12 h after initial evaluation)
- TEE preferred; obtain TTE views of any abnormal findings for later
comparison
- TTE if TEE is not immediately available
- TTE may be sufficient in small children
- Repeat echocardiography
- TEE after positive TTE as soon as possible in patients at high risk for
complications
- TEE 7–10 d after initial TEE if suspicion exists without diagnosis of IE
or with worrisome clinical course during early treatment of IE
|
|
90
|
- Intraoperative x
- Identification of vegetations, mechanism of regurgitation,
abscesses, fistulas, and pseudoaneurysms
- Confirmation of successful repair of abnormal findings
- Assessment of residual valve dysfunction
- Elevated afterload if necessary to avoid underestimating valve
insufficiency or presence of residual abnormal flow
- Completion of therapy
- Establish new baseline for valve function and morphology and ventricular
size and function TTE usually adequate; TEE or
review of intraoperative TEE may be needed for complex anatomy to
establish new baseline
|
|
91
|
- Vegetation x
- Persistent vegetation after systemic embolization
- Anterior mitral leaflet vegetation, particularly with size >10 mm
- 1 embolic events during first 2 wk of antimicrobial therapy
- Increase in vegetation size despite appropriate antimicrobial therapy*
|
|
92
|
- Valvular dysfunction x
- Acute aortic or mitral insufficiency with signs of ventricular failure
- Heart failure unresponsive to medical therapy
- Valve perforation or rupture
- Perivalvular extension
- Valvular dehiscence, rupture, or fistula
- New heart block
- Large abscess or extension of abscess despite appropriate antimicrobial
therapy
|